Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Osteoporosis

Free Subscription 03.11.2025 5 J Bone Miner Res 8 Osteoporos Int 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

J Bone Miner Res

1. OSTERTAG A, Leger B, Koumakis E, Fardellone P, et al
   Impaired organic and mineral extracellular matrix composition in early-onset osteoporosis.
   J Bone Miner Res. 2025 Oct 30:zjaf159. doi: 10.1093.
   PubMed         Abstract available
   
   
2. BONNET AL, Aboishava L, Mannstadt M
   Advances in Parathyroid Hormone-based medicines.
   J Bone Miner Res. 2025;40:1195-1206.
   PubMed         Abstract available
   
   
3. MOLLER S, Rietz M, Petersen FL, Brond JC, et al
   An enhanced fracture risk evaluation model (FREM) using national health data on morbidity and medications.
   J Bone Miner Res. 2025 Oct 31:zjaf156. doi: 10.1093.
   PubMed         Abstract available
   
   
4. JOHANNESDOTTIR F, Aspelund T, Mahar S, Sigurdsson S, et al
   The relationship between fall risk, trochanteric soft tissue thickness, and hip fracture risk in older adults.
   J Bone Miner Res. 2025 Oct 31:zjaf161. doi: 10.1093.
   PubMed         Abstract available
   
   
5. WU Q, Jung J
   Uncovering Racial and Genetic Disparities in FRAX Performance for Fracture Risk Assessment in Postmenopausal Women.
   J Bone Miner Res. 2025 Oct 30:zjaf160. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Osteoporos Int

6. ABDALBARY M, Amin AM, Elaraby A, Hassan A, et al
   Efficacy and safety of romosozumab in patients with chronic kidney disease and osteoporosis: a narrative review.
   Osteoporos Int. 2025 Oct 31. doi: 10.1007/s00198-025-07707.
   PubMed         Abstract available
   
   
7. KIM J, Kwak S, Lee H, Chang J, et al
   Explainable opportunistic osteoporosis screening from chest X-rays: a retrospective comparison of foundation models.
   Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07727.
   PubMed         Abstract available
   
   
8. FALK SSI
   Author response to letter to the editor to ankle fractures: A pragmatic opportunity for osteoporosis case finding (OSIN-D-25-01889).
   Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07748.
   PubMed        
   
   
9. TSUKAMOTO M, Hamasaki T, Okimoto N, Saito Y, et al
   Author's response to letter to editor "Comment on: Effectiveness of treatment initiation for secondary fracture prevention in the older population: Japanese Bone-fracture Osteoporosis in Late-stage population Database study (J-BOLD)-emulation of a ran
   Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07739.
   PubMed        
   
   
10. SENDHIL SR, Cadarette SM, Aggarwal S, Oganisian A, et al
    Follow-on osteoporosis therapy after denosumab discontinuation among Medicare beneficiaries.
    Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07668.
    PubMed         Abstract available
    
    
11. BUGBIRD AR, Burt LA, Whittier DE, Boyd SK, et al
    Localized bone deterioration predicts declining failure load and increased fracture risk.
    Osteoporos Int. 2025 Oct 29. doi: 10.1007/s00198-025-07750.
    PubMed         Abstract available
    
    
12. RAHMANI A, Weichelt U, Jahn D, Otto E, et al
    Beyond the initial impact: a systematic review of post-traumatic bone loss and its mechanisms.
    Osteoporos Int. 2025 Oct 28. doi: 10.1007/s00198-025-07716.
    PubMed         Abstract available
    
    
13. HOSSEINPOUR M
    Clarifying the interpretation of metapgs and cumulative incidence in fracture risk prediction.
    Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07741.
    PubMed        
    
    

    
    PLoS One

14. LONG C, Li X, Fan Y, Hu Y, et al
    Effects and mechanisms of engineered exosomes pretreated with Scutellaria baicalensis Georgi on osteoporosis.
    PLoS One. 2025;20:e0333897.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge.